Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

Cofoe Medical Technology / Equity Capital Markets

<ul>
<li>Cofoe Medical Technology, a home care medical devices provider in China, is seeking dual listing and has launched HK IPO consisting of 27M H shares at HK$39.33 per share.</li>
<li>The subscription period will close on April 30. The company intends to raise $136M to fund for global expansion, R&amp;D, domestic distribution network enhancement, and branding and marketing activities.</li>
<li>Despite competition and fragmented market, ability to record volume growth for almost all of the key products and margin improvement enhance conviction on the sustainable growth prospect of the company.</li>
</ul>


Cofoe Medical Technology, a home care medical devices provider in China, is seeking dual listing and has launched HK IPO consisting of 27M H shares at HK$39.33 per share.
The subscription period will close on April 30. The company intends to raise $136M to fund for global expansion, R&amp;D, domestic distribution network enhancement, and branding and marketing activities.
Despite competition and fragmented market, ability to record volume growth for almost all of the key products and margin improvement enhance conviction on the sustainable growth prospect of the company.


Jiangsu Yuyue Medical Equipment & Supply A (002223 CH)

Jiangsu Yuyue Medical Equipment & Supply A

Cofoe Medical IPO: Portfolio Optimization Remains Key to Float Amid Fierce Competition